AOD-9604
Anti-Obesity Drug 9604 (hGH Fragment 176-191)
A fragment of human growth hormone (amino acids 176-191) that retains the fat-burning properties of GH without the anabolic or diabetogenic effects.
Mechanism of Action
AOD-9604 stimulates lipolysis and inhibits lipogenesis by mimicking the lipolytic region of GH. It activates beta-3 adrenergic receptors in fat tissue, promoting fat breakdown without affecting blood glucose or IGF-1 levels.
Health Claims & Evidence
Promotes fat loss and lipolysis
No effect on blood glucose or insulin sensitivity
May support cartilage and bone repair
Short-Term Effects
Gradual fat loss, particularly in abdominal region. No significant appetite changes.
Long-Term Effects
Sustained fat loss with consistent use. No anabolic or hormonal side effects.
Side Effects
Generally very well-tolerated. Mild injection site reactions. No hormonal disruption.
Contraindications
Limited data in pregnancy. Generally considered safe for most adults.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
AOD-9604 and fat metabolism
Heffernan et al. · Journal of Endocrinology · 2001
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on AOD-9604 and related peptides, and prepare an educational research summary.
Explore Research